Frontlight ResearchEarly access
Trial site
Universidade Federal de Goias
- 7running trials
- 5closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Heart failure3 trials
- Obesity3 trials
- Coronary artery disease2 trials
- Peripheral artery disease2 trials
- Stroke2 trials
- Chronic kidney disease1 trial
- Crohn's disease1 trial
- Familial hypercholesterolaemia1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- High blood pressure1 trial
- Primary biliary cholangitis1 trial
- Type 1 diabetes1 trial
- and 2 more
- Phase
- Phase 38 trials
- Phase 21 trial
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company7 trials
- Hospital Israelita Albert Einstein3 trials
- Hospital do Coracao1 trial
- Ipsen1 trial
Running trials
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Peripheral artery disease1 recruiting
- Primary biliary cholangitis1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Terminated
Completed
Completed
Completed
Completed
Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Stroke Patients
Site data: ClinicalTrials.govUpdated 13 Nov 2026